Kedrion is an international biopharmaceutical company that specializes in the collection and fractionation of blood plasma to produce and distribute plasma-derived therapies worldwide. With a focus on treating and preventing serious diseases like Hemophilia, Primary immunodeficiencies, and Rh sensitization, Kedrion plays a crucial role in improving the lives of individuals suffering from these conditions. Founded in Italy in 2001, Kedrion has a rich history in the production of plasma-derived products.

In 2022, the company joined forces with Bio Products Laboratory (BPL), a UK-based company with over 60 years of experience in the supply of high-quality plasma-derived medicines. This collaboration further strengthens Kedrion's commitment to tackling rare diseases. Operating in over 100 countries, with 7 production plants across Europe and North America, Kedrion is a global player in the field of plasma derivatives.

The company employs more than 4,800 individuals and operates plasma collection centers in the United States and Czech Republic. Committed to social responsibility, Kedrion prioritizes the welfare of its beneficiaries and actively collaborates with communities and institutions. Their vision revolves around ensuring that everyone has the right to life, liberty, and security, and Kedrion strives to remove any obstacles preventing the enjoyment of these fundamental rights.

With a strong focus on quality, safety, and transparency, Kedrion constantly works towards maintaining excellent industry standards and strengthening its role as a trusted partner for medical, scientific, and institutional communities. The company's mission is to produce and distribute human plasma-derived products, contribute to the self-sufficiency of national health systems, and create value for investors, employees, and local communities. In summary, Kedrion is a leading biopharmaceutical brand dedicated to producing and providing plasma-derived therapies to address rare and debilitating diseases.

With a global reach, extensive expertise, and a commitment to social responsibility, Kedrion continues to make a significant impact in the field of medical research and innovation